These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2068485)

  • 21. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal and perinatal correlates of adult mammographic breast density.
    Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cancer risk in breast lesions: diagnostic and therapeutic strategy].
    Bove F; Bilancio G; De Falco M; Parmeggiani D; Sperlongano P; Barbarisi A; Parmeggiani U
    Minerva Chir; 2003 Jun; 58(3):375-83. PubMed ID: 12955059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypia in the assessment of breast cancer risk: implications for management.
    Vogel VG
    Diagn Cytopathol; 2004 Mar; 30(3):151-7. PubMed ID: 14986294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.
    Cahn MD; Tran T; Theur CP; Butler JA
    Am Surg; 1997 Oct; 63(10):858-60. PubMed ID: 9322657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk factors in younger and older women.
    Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
    Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cancer of the breast. I. Epidemiology and risk factors (our experience)].
    Macellari G; Giarelli C
    Minerva Chir; 1989 Jun; 44(12):1655-8. PubMed ID: 2771117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign breast disease and breast cancer risk: potential role for antiestrogens.
    Schnitt SJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4419s-4422s; discussion 4411s-4412s. PubMed ID: 11916234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Chang SC; Ziegler RG; Dunn B; Stolzenberg-Solomon R; Lacey JV; Huang WY; Schatzkin A; Reding D; Hoover RN; Hartge P; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):334-41. PubMed ID: 16492925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of mastopathies at risk].
    Pons JY
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):29-32. PubMed ID: 2068482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What is mastopathy at risk? Epidemiologic and clinical basis].
    Gorins A; Kottler ML
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):4-8. PubMed ID: 2068485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [When must a mastopathy at risk be operated on? The viewpoint of the clinician, the radiologist, the surgeon, and the anatomopathologist].
    Gorins A; Dilhuydy MH; Petit JY; Contesso G
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):15-20. PubMed ID: 2068479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mastopathy. Histological forms and long-term observations].
    Prechtel K
    Zentralbl Pathol; 1991; 137(3):210-9. PubMed ID: 1931894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.